Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:42 PM
Ignite Modification Date:
2025-12-24 @ 11:42 PM
NCT ID:
NCT04467151
Eligibility Criteria:
Inclusion Criteria:
* Patients ≥18 years of age
* Hospitalized with COVID-19-related acute respiratory symptoms
* Initial COVID-19 severity status on the WHO Ordinal Scale for Clinical Improvement = 3 ("Hospitalized, no oxygen therapy) or 4 ("Hospitalized, on oxygen by mask or nasal prongs")
* Laboratory-confirmed COVID-19
* First signs of infection occurring no more than 14 days prior to enrollment
Exclusion Criteria:
* Receipt of pooled immunoglobulin in the past 30 days
* Contraindication to transfusion or history of prior reactions to transfusion blood products
* Admission to intensive care unit at any point during hospital course prior to enrollment
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04467151
Study Brief:
Protocol Section:
NCT04467151